Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study.
Léna RoystonStéphane IsnardCarolina A BeriniSimeng BuPeter L LakatosTalat BessissowNicolas ChomontMarina KleinBertrand LebouchéAlexandra De PokomandyNadine KronfliCecilia T CostiniukRejean ThomasCécile TremblayGuy BoivinJean-Pierre RoutyPublished in: BMJ open (2023)
NCT05362916.
Keyphrases
- open label
- antiretroviral therapy
- clinical trial
- study protocol
- randomized controlled trial
- hiv infected
- oxidative stress
- phase ii
- human immunodeficiency virus
- phase iii
- hiv aids
- phase ii study
- hiv infected patients
- hiv positive
- double blind
- squamous cell carcinoma
- radiation therapy
- hepatitis c virus
- locally advanced